261 related articles for article (PubMed ID: 23624617)
1. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany.
Lorenz K; Wolfram C; Breitscheidel L; Shlaen M; Verboven Y; Pfeiffer N
Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2019-28. PubMed ID: 23624617
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
Lee PP; Walt JG; Doyle JJ; Kotak SV; Evans SJ; Budenz DL; Chen PP; Coleman AL; Feldman RM; Jampel HD; Katz LJ; Mills RP; Myers JS; Noecker RJ; Piltz-Seymour JR; Ritch RR; Schacknow PN; Serle JB; Trick GL
Arch Ophthalmol; 2006 Jan; 124(1):12-9. PubMed ID: 16401779
[TBL] [Abstract][Full Text] [Related]
3. Resource use and costs for a glaucoma screening program in Austria: an 8-year review: a cost-consequence analysis based on the Salzburg-Moorfields Collaborative Glaucoma Study.
Hitzl W; Ortner C; Hornykewycz K; Grabner G; Reitsamer HA
Eur J Ophthalmol; 2006; 16(1):92-9. PubMed ID: 16496251
[TBL] [Abstract][Full Text] [Related]
4. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States.
Kobelt-Nguyen G; Gerdtham UG; Alm A
J Glaucoma; 1998 Apr; 7(2):95-104. PubMed ID: 9559495
[TBL] [Abstract][Full Text] [Related]
5. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
[TBL] [Abstract][Full Text] [Related]
6. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
Eye (Lond); 2008 Mar; 22(3):354-62. PubMed ID: 17128205
[TBL] [Abstract][Full Text] [Related]
8. [An observational, retrospective two-year cost study in primary open-angle glaucoma and ocular hypertension in newly diagnosed patients].
Rouland JF; Peigne G; Sellem E; Renard JP; Williamson W; Filippi JM; Cohn H; Hamard P; Abellan P; Chagnon A; Malet F; Haye I
J Fr Ophtalmol; 2001 Mar; 24(3):233-43. PubMed ID: 11285438
[TBL] [Abstract][Full Text] [Related]
9. Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.
Kobelt G; Jönsson L; Gerdtham U; Krieglstein GK
Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):811-21. PubMed ID: 9825256
[TBL] [Abstract][Full Text] [Related]
10. Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches.
Orme M; Collins S; Loftus J
J Glaucoma; 2012 Sep; 21(7):433-49. PubMed ID: 21677590
[TBL] [Abstract][Full Text] [Related]
11. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
12. Medical predictive factors of glaucoma treatment costs.
Denis P; Lafuma A; Berdeaux G
J Glaucoma; 2004 Aug; 13(4):283-90. PubMed ID: 15226656
[TBL] [Abstract][Full Text] [Related]
13. Cost of glaucoma in Canada: analyses based on visual field and physician's assessment.
Iskedjian M; Walker J; Vicente C; Trope GE; Buys Y; Einarson TR; Covert D
J Glaucoma; 2003 Dec; 12(6):456-62. PubMed ID: 14646678
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of treating ocular hypertension.
Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
[TBL] [Abstract][Full Text] [Related]
15. Comparison of resource utilization in the treatment of open-angle glaucoma between two cities in Finland: is more better?
Hagman J
Acta Ophthalmol; 2013 May; 91 Thesis 3():1-47. PubMed ID: 23621767
[TBL] [Abstract][Full Text] [Related]
16. Progression from ocular hypertension to visual field loss in the English hospital eye service.
Kelly SR; Khawaja AP; Bryan SR; Azuara-Blanco A; Sparrow JM; Crabb DP
Br J Ophthalmol; 2020 Oct; 104(10):1406-1411. PubMed ID: 32217541
[TBL] [Abstract][Full Text] [Related]
17. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
[TBL] [Abstract][Full Text] [Related]
18. The treatment of newly diagnosed patients with glaucoma or with ocular hypertension in The Netherlands: an observational study of costs and initial treatment success based on retrospective chart review.
Oostenbrink JB; Rutten-van Mölken MP; Opdenoordt TS
Doc Ophthalmol; 1999; 98(3):285-99. PubMed ID: 10945448
[TBL] [Abstract][Full Text] [Related]
19. Naturalistic, prospective study of glaucoma and ocular hypertension treatment in France: Strategies, clinical outcomes, and costs at 2 years.
Rouland JF; Le Pen C; Benhaddi H; Piriou E; Lilliu H; Kenigsberg PA;
Eur J Ophthalmol; 2005; 15(5):562-80. PubMed ID: 16167287
[TBL] [Abstract][Full Text] [Related]
20. Healthcare charges in patients who transition from ocular hypertension to primary open-angle glaucoma based on ophthalmic coding data.
Pasquale LR; Walt JG; Stern LS; Wiederkehr D; Malangone E; Dolgitser M
Adv Ther; 2009 Oct; 26(10):947-58. PubMed ID: 19907929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
